Phase I Study of 131I-Labeled Humanized Antibody A33 in Patients With Advanced Colorectal Carcinoma
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Monoclonal antibody A33 I-131 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- 17 Dec 2009 Actual end date (Aug 2000) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Sep 2005 New trial record.